Massachusetts General Hospital

People suffering from ALS (amyotrophic lateral sclerosis) often have difficulty raising their arms, due to deterioration of cells in their brain and spinal cord. A new wearable system is designed to help, utilizing a pair of under-arm balloons.

One way scientists hope to lighten the burden of type 1 diabetes is through transplantation of cells that produce insulin, and novel bead-like materials offer new hope by reducing the need for immunosuppressant drugs with severe side effects.

Since the beginning of the pandemic, doctors have seen links between COVID-19 and diabetes, but is the novel coronavirus directly causing new cases of diabetes, or are we just catching more undiagnosed diabetes cases? A new study offers some answers.

A new study has identified a pattern of brain activity that seems to correlate with impairment from cannabis intoxication. The researchers suggest this novel brain-based biomarker could be a way to accurately measure THC impairment.

The results have been revealed from a study testing an algorithm designed to detect irregular heart rhythms using data from wearables. Enrolling nearly half a million subjects, the study detected undiagnosed atrial fibrillation in 98 percent of cases.

A new imaging study comparing brain activity of superagers to youthful brains highlights exactly how some older adults can maintain good memory function, and directs researchers to brain regions that could be stimulated to enhance memory in aging adults.

Fascinating new research has found a link between opioid addiction and vitamin D deficiency. The research indicates subjects with low vitamin D levels may experience heightened euphoric effects from opioids, making them more susceptible to addiction.

Researchers at Massachusetts General Hospital have identified an enzyme that may naturally protect the brain from damage caused by oxygen deprivation. This could be a potential drug target to prevent issues arising from strokes or heart attacks.

One of cancer’s crafty tricks involves manipulating the host’s immune cells to protect tumors instead of fighting them. Now researchers at Massachusetts General Hospital have turned the tables again, transforming these cells back into cancer killers.

A new review article is presenting a promising case for phenformin, an old diabetes drug related to metformin, being repurposed as an adjunct to new immunotherapy cancer treatments. A phase 1 clinical trial is underway to test the novel combination.

Harmful clusters of certain proteins are seen as key players in the cognitive decline associated with Alzheimer's disease, and scientists have now found that a novel gene therapy may be able to prevent a significant portion of them from forming.

Heart attacks occur when plaque deposits break off of blood vessel walls, subsequently blocking arteries that carry oxygen to the heart. A new imaging process could identify those unstable deposits, allowing them to be treated before they rupture.